LIN28B gene identified as essential for fetal B-cell development and initiation of KMT2A::AFF1 infant leukemia
By
Ling, Rebecca E, Welsh, Alia M, Hamer, Lucy, Jackson, Thomas, Neil, Emily, Elliott, Natalina, Cross, Joe Wilson, Wuppalapati, Arundhati Siddhartha, Smith, Alastair L, Chahrour, Catherine, Sevim, Okan, Palmer, David A, Bozhilov, Yavor, Brown, Elizabeth J, Olender, Leonid, Iskander, Deena, Wang, Guanlin, Rice, Siobhan, O'Byrne, Sorcha, Harman, Joe, Ancliff, Philip, Psaila, Bethan, Wilkinson, Adam C., Morgan, Rhys G, Roberts, Irene AG, Milne, Thomas A, Roy, Anindita
Summary
This scientific research article reports that the fetal-specific gene LIN28B is essential for human fetal B-lymphopoiesis (the development of B cells in the fetus) and plays a critical role in initiating KMT2A::AFF1 infant leukemia, a type of B-cell acute lymphoblastic leukemia (B-ALL) that affects infants. The study identifies LIN28B as a fetal-specific oncogene necessary for both normal fetal B cell development and the initiation of this aggressive infant leukemia.
Source
Key quotes
· 3 pulledThe fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemia
LIN28B, a fetal specific oncogene, is necessary for fetal B lymphopoiesis and KMT2A::AFF1 initiation of infant B ALL
LIN28B stabilizes key fetal
You might also wanna read

Pan-cancer AI atlas reveals diversity and spatial organization of tertiary lymphoid structures in tumors
Researchers built a pan-cancer atlas of tertiary lymphoid structures (TLSs) in human tumors, developing an AI-based framework to detect and
Single-cell map of the healthy human immune system across the lifespan reveals unique infant immune signatures
Newborns have elevated levels of a biomarker for Alzheimer's

Study reveals CXCL16-driven γδ T cell brain infiltration reduces sociability in autism mouse model
This study investigates the role of immune cells, specifically γδ T cells, in autism spectrum disorder (ASD) using a mouse model of 15q11-13
Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification
Researchers used a new 27 billion parameter foundation model called C2S-Scale 27B, built on Google's Gemma family of open models, to discove

Comments
Sign in to join the conversation.
No comments yet. Be the first.